Clinical Trial Update: Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

View source ↗

Summary

This clinical trial update describes the use of tumor-targeted NIR-II fluorescent probes to identify breast cancer tissue and determine sentinel lymph node meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Breast Cancer, Sentinel Lymph Node | Status: RECRUITING